Centre proposes immediate suspension of licences for substandard drugs
The Health Ministry has introduced new regulations aimed at suspending manufacturing licenses for medicines that do not meet quality criteria. This swift action is intended to stop subpar drugs from reaching patients and to minimize their circulation during the regulatory review. Licenses can be su…
Read the full story on Times of India Opens timesofindia.indiatimes.com in a new tab
Advertisement
CallZenixAI Voice Bot, Dialer & IVR SolutionsCloud dialer and contact-center software for your teamKnow more
This is a short summary of a story published by Times of India, shown with a link to the original. The full story, photo and reporting belong to Times of India.











